The decreased expression of IL-4 in the tumor microenvironment of IPI-549/PD-L1 treated tumor-bearing mice further emphasizes the anti-tumor effect of combined PI3Kγ and PD-L1 inhibition. This evidence concerns the gene IL4 and neoplasm.